Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

pembrolizumab 8 Paclitaxel 8 Carboplatin 6 Megestrol Acetate 4 niraparib 3 Cisplatin 3 tislelizumab 2 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 rucaparib 2 olaparib 2 iso-sulfan blue 2 copanlisib 2 Taxes 2 Surveys and Questionnaires 2 Nivolumab 2 Lymph Node Excision 2 Indocyanine Green 2 Fulvestrant 2 Filgrastim 2 Doxorubicin 2 Docetaxel 2 tremelimumab 1 spartalizumab 1 sonidegib 1 ribociclib 1 rebastinib 1 pemigatinib 1 nicotinamide-beta-riboside 1 lenvatinib 1 ixabepilone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Endometrial Neoplasms × Megestrol × Clear all

NCT05332483 2023-11-03

MA-EEC

Sunnybrook Health Sciences Centre

Phase 1 Terminated

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡